Year archive

Laekna, Inc. — 2025 filings

All 42 regulatory filings released by Laekna, Inc. (2105) in 2025, sourced directly from the official regulator.

42 Filings

2025 Period

2025 filings (42)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT FIRST SUBJECT DOSED IN PHASE I SINGLE ASCENDING DOSE STUDY OF LAE103 Regulatory Filings	2025-12-31	English
VOLUNTARY ANNOUNCEMENT FIRST SUBJECT DOSED IN PHASE I MULTIPLE DOSE EXPANSION STUDY OF LAE102 FOR THE TREATMENT OF OBESITY Regulatory Filings	2025-12-22	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT IN PHASE III CLINICAL TRIAL (AFFIRM-205) OF LAE002 (AFURESERTIB) IN HR+/HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER Regulatory Filings	2025-12-15	English
Terms of Reference for the Nomination and Corporate Governance Committee Governance Information	2025-12-12	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-12-12	English
CHANGE OF THE COMPOSITION OF THE NOMINATION AND CORPORATE GOVERNANCE COMMITTEE Board/Management Information	2025-12-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-03	English
INSIDE INFORMATION EXCLUSIVE LICENSE AGREEMENT WITH QILU PHARMA FOR LAE002 (AFURESERTIB) IN THE CHINA REGION M&A Activity	2025-11-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Share Issue/Capital Change	2025-10-08	English
VOLUNTARY ANNOUNCEMENT POSITIVE PRELIMINARY RESULTS FROM THE PHASE I MAD STUDY LAE102 DEMONSTRATED ENCOURAGING TREND TOWARDS LEAN BODY MASS INCREASE AND FAT MASS REDUCTION Regulatory Filings	2025-09-29	English
Next Day Disclosure Return Share Issue/Capital Change	2025-09-17	English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-09-17	English
PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-09-10	English
Next Day Disclosure Return Transaction in Own Shares	2025-09-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Share Issue/Capital Change	2025-09-04	English
Interim Report 2025 Interim / Quarterly Report H1 2025	2025-08-21	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H1 2025	2025-08-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-05	English
VOLUNTARY ANNOUNCEMENT INVESTIGATIONAL NEW DRUG APPROVAL FOR LAE103 WAS OBTAINED FROM THE U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2025-07-31	English
DATE OF BOARD MEETING Report Publication Announcement	2025-07-29	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-04	English
VOLUNTARY ANNOUNCEMENT SUBMISSION OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LAE103 TO THE U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2025-06-30	English
VOLUNTARY ANNOUNCEMENT PRESENTATIONS OF CLINICAL AND PRECLINICAL STUDIES RESULTS OF LAE02, LAE03 AND LAE123 AT 2025 ADA Regulatory Filings	2025-06-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 3 JUNE 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-03	English
PROXY FORM FOR THE ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-12	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-12	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES, RESELL TREASURY SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; PROPOSED GRAN Proxy Solicitation & Information Statement	2025-05-12	English
GRANT OF RESTRICTED SHARE UNITS Remuneration Information	2025-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Share Issue/Capital Change	2025-05-06	English
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Environmental & Social Information	2025-04-23	English
2024 ANNUAL REPORT Regulatory Filings	2025-04-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-07	English
VOLUNTARY ANNOUNCEMENT SUBMISSION OF IND AMENDMENT TO U.S. FDA FOR LAE102 FOR THE TREATMENT OF OBESITY Regulatory Filings	2025-03-31	English
VOLUNTARY ANNOUNCEMENT FIRST VISIT FOR THE FIRST SUBJECT COMPLETED IN PHASE I MULTIPLE ASCENDING DOSE STUDY OF LAE102 FOR THE TREATMENT OF OBESITY Regulatory Filings	2025-03-26	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-24	English
DATE OF BOARD MEETING Regulatory Filings	2025-03-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Share Issue/Capital Change	2025-03-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF A SUCCESSFUL PHASE I SAD STUDY OF LAE102 FOR THE TREATMENT OF OBESITY Regulatory Filings	2025-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-06	English